BRIEF published on 07/16/2026 at 09:12, 30 days 4 hours ago Valerio Therapeutics and Abivax join forces for innovative therapies Abivax Collaboration Inflammatory Diseases Valerio Therapeutics RNA Therapies
BRIEF published on 07/16/2026 at 09:12, 30 days 4 hours ago Valerio Therapeutics et Abivax s'allient pour des thérapies innovantes Abivax Collaboration Maladies Inflammatoires Valerio Therapeutics Thérapies ARN
BRIEF published on 07/16/2026 at 09:12, 30 days 4 hours ago Valerio Therapeutics s'associe à Abivax pour le développement de thérapies à base d'ARN Biotechnologie Valerio Thérapeutique Pipelines Thérapies À Base D'ARN Collaboration Abivax
BRIEF published on 07/16/2026 at 09:12, 30 days 4 hours ago Valerio Therapeutics Partners with Abivax for RNA Therapeutics Development Biotechnology Valerio Therapeutics Pipelines RNA Therapeutics Abivax Collaboration
PRESS RELEASE published on 07/16/2026 at 09:07, 30 days 4 hours ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce une collaboration de développement avec Abivax, met à jour son pipeline de thérapies de précision ARN Développement Abivax Collaboration Pipeline Valerio Therapeutics
PRESS RELEASE published on 07/16/2026 at 09:07, 30 days 4 hours ago Inside Information / Other news releases Valerio Therapeutics partners with Abivax for global collaboration, providing pipeline update on RNA therapeutics. Initial payment up to €2.4 million Abivax Collaboration Valerio Therapeutics Pipeline Update RNA Therapeutics
BRIEF published on 07/01/2026 at 09:27, 1 month 14 days ago Valerio Therapeutics prépare l'acquisition d'Etherna Immunotherapies Valerio Therapeutics Investissement Biotechnologie Acquisition Etherna Médicaments ARN Fusion Entreprises
BRIEF published on 07/01/2026 at 09:27, 1 month 14 days ago Valerio Therapeutics Proposes to Acquire Etherna Immunotherapies Biotechnology Valerio Therapeutics Acquisition Deal RNA Medicines Etherna Immunotherapies
BRIEF published on 07/01/2026 at 09:27, 1 month 14 days ago Valerio Therapeutics propose d'acquérir Etherna Immunotherapies Biotechnologie Accord D'acquisition Valerio Thérapeutique Médicaments À Base D'ARN Immunothérapies Etherna
BRIEF published on 07/01/2026 at 09:27, 1 month 14 days ago Valerio Therapeutics is preparing to acquire Etherna Immunotherapies Valerio Therapeutics Biotechnology Investment Etherna Acquisition RNA Drugs Mergers Of Companies
Published on 08/15/2026 at 00:50, 12 hours 57 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 13 hours 32 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 14 hours 2 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 14 hours 22 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 14 hours 47 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/15/2026 at 08:05, 5 hours 42 minutes ago SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:15, 19 hours 32 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 21 hours 42 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/13/2026 at 18:00, 1 day 19 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 20 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 20 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 19 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 19 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
